Forensic Genomics Announces Partnership with International Symposium on Human Identification

-Forensic Genomics is pleased to announce its new partnership agreement with the International Symposium on Human Identification(ISHI). This annual symposium began over 30 years ago and has grown to become the world’s largest conference focused on technologies, policies and innovations in forensic DNA analysis for human identification. DNA experts and analysts from around the world come together to share the latest scientific advances, announce new product concepts and debate policy issues. The conference is open to all practitioners and providers of DNA analysis for human identification

“ISHI aims to facilitate collaboration to advance the forensic science of DNA. We are thrilled to partner with Forensic Genomics as the official journal of ISHI to provide attendees with a new way to learn and apply the latest technologies and groundbreaking research to the vital work they do. says Carol Bingham, symposium leader.

“Editors Mary Ann Liebert are delighted to announce our new partnership between our journal, Forensic Genomics, and the Promega International Symposium on Human Identification. This partnership will provide educational and promotional synergies between the journal and the symposium, supporting our shared mission to advance DNA technology to enable human identification,” said Bob Vrooman, director of business development for Mary Ann Liebert, Inc., publishers.

ISHI is sponsored by Promega Corporation, a global biotechnology company that provides innovative solutions and technical support to the life science industry, including products for DNA-based human identification. The company’s product portfolio supports scientific advancements in academic, pharmaceutical, clinical, forensic and industrial/environmental laboratories worldwide. Promega is headquartered in Madison, WI, with branches in 16 countries.

About the journal

Forensic Genomics is a new peer-reviewed journal that explains how advances in genetic testing and genomic analysis can allow researchers to break through previously impenetrable forensic DNA barriers. Led by Managing Editor David Mittelman, PhD, Founder and CEO of Othram, Inc., the Journal focuses on the use of DNA testing technologies, algorithms, artificial intelligence, and genealogical research methods to support human identification using inference tools and inductive reasoning. Forensic Genomics aims to accelerate the validation and adoption of new methods to support investigations that would otherwise be stuck with traditional testing methods. For complete information, visit the Forensic Genomics website.

About the editor

Mary Ann Liebert, Inc., publishers is known for creating authoritative, peer-reviewed journals in many promising areas of science and biomedical research. Its specialized biotechnology magazine, GEN (Genetic Engineering and Biotechnology News), was the first in its field and is today the most widely read industry publication in the world. A complete list of the firm’s 90 journals, newsmagazines and books is available on the Mary Ann Liebert, Inc., publishers website.

/Public release. This material from the original organization/authors may be ad hoc in nature, edited for clarity, style and length. The views and opinions expressed are those of the author or authors.View Full here.

Comments are closed.